How common is intraoperative pain occur during caesarean delivery surgery when the patient is awake and what is the impact on mothers?

ISRCTN ISRCTN15269213
DOI https://doi.org/10.1186/ISRCTN15269213
IRAS number 265964
Secondary identifying numbers CPMS 58492, IRAS 265964, WKR0 - 2019 - 0036
Submission date
03/06/2024
Registration date
24/03/2025
Last edited
24/03/2025
Recruitment status
Recruiting
Overall study status
Ongoing
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
We do not have very good information about how well neuraxial anaesthesia (anaesthesia that aims to numb part of your body whilst remaining awake) during caesarean section performs, nor how intraoperative pain should be managed, or what the outcomes are for patients who experience pain during awake caesarean sections.
The aims of this study are to:
1. Estimate how often awake caesarean section surgery fails and intraoperative pain is experienced
2. Use patient-centred tools to assess the impact on patients who experience pain during awake caesarean section

Who can participate?
Every adult patient aged 18 years and over who has a caesarean section, including if the caesarean section is planned or unplanned (an urgent or emergency case), at any time of day or night, and is done awake using NA.

What does the study involve?
There will be three points of data collection.
Form 1 will be completed by the responsible anaesthetist for the case. It will collect basic anaesthetic, obstetric, and surgical information. There will be nothing on Form 1 that is not already routinely collected by hospitals for all caesarean sections.
Form 2 will be filled in by the researcher together with the patient between 18 and 30 hours after the caesarean. It will consist of questions regarding their experience of the caesarean section, any intraoperative pain or discomfort they may have experienced, their satisfaction with the anaesthetic care, and the quality of the recovery. It is estimated that this will take about 10-15 minutes.
Form 3 will be filled in by a researcher who calls the patient about 6 weeks after the caesarean section. The form will consist of questionnaires to help identify the impact to those who have had any negative experiences, compared to those who did not. These are validated questionnaires that are used to identify post-traumatic stress and post-natal depression. This will probably take about 10-15 minutes.
Should a patient score above a specific threshold on these Form 3 questionnaires, they will receive a letter informing them, with a list of resources. Their GP will also be informed by letter.

What are the possible benefits and risks of participating?
There will be no specific benefit for the participants by taking part. For the future, the results of this study will help us to better understand and manage pain during caesarean section, but also have better information when consenting patients for caesarean section and discussing risks.
The researchers do not think there are any disadvantages or risks to taking part. There is a small possibility that answering the questionnaire may cause you to worry or feel anxious about your anaesthetic or your recovery. Some of the questions asked at the 6-week telephone call will be about your current mood. In this call, the researchers will be using questionnaires aiming to screen for anxiety, depression, and post-traumatic stress, If the questionnaire scores suggest that you might have such symptoms, then the researchers will let you know at the time, and encourage you to visit your GP if you think that’s right. The researchers will also write to you and your GP, letting them know. The letter for you will include resources and groups available to you, that you may find beneficial.

Where is the study run from?
University College London Hospital (UK)

When is the study starting and how long is it expected to run for?
April 2019 to August 2025

Who is funding the study?
1. National Institute of Academic Anaesthesia (NIAA) (UK)
2. NIHR Central London Patient Safety Research Collaboration (UK)

Who is the main contact?
Prof. Ramani Moonesinghe, Ramani.moonesinghe@nhs.net

Contact information

Prof Ramani Moonesinghe
Principal Investigator

University College London Hospital
235 Euston Road
London
NW1 2BU
United Kingdom

ORCiD logoORCID ID 0000-0002-6730-5824
Email Ramani.moonesinghe@nhs.net
Dr Reshma Patel
Scientific

University College London Hospital
235 Euston Road
London
NW1 2BU
United Kingdom

ORCiD logoORCID ID 0000-0002-5577-886X
Email Reshma.patel21@nhs.net
Dr James O’Carroll
Scientific

University College London Hospital
235 Euston Road
London
NW1 2BU
United Kingdom

ORCiD logoORCID ID 0000-0001-7070-2276
Email James.ocarroll@nhs.net

Study information

Study designNon-randomized; Both; Design type: Screening, Diagnosis, Education or Self-Management, Management of Care, Cohort study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet 45562_PIS.pdf
Scientific titleSnapshot obstetric national anaesthetic research project 1 (SONAR-1)
Study acronymSONAR 1
Study hypothesisStudy hypothesis:
Intraoperative pain during awake caesarean section has a negative impact on short- and medium-term postoperative outcomes.

Research Questions:
RQ1: What is the incidence of intraoperative pain reported by patients during caesarean birth performed with neuraxial anaesthesia?
RQ2 What is the incidence of incidence of intraoperative pain reported by clinicians during caesarean birth performed with neuraxial anaesthesia?
RQ3: What are the hospital, patient, clinician, anaesthetic, and obstetric-related factors associated with the incidence of pain during caesarean birth performed under neuraxial anaesthesia?
RQ4: What are the hospital, clinician, patient, anaesthetic, and obstetric-related factors associated with the short- and longer-term outcomes following caesarean birth performed under neuraxial anaesthesia?

Objectives:
1. To estimate the incidence of patient and clinician-reported intraoperative pain during caesarean birth conducted with neuraxial anaesthesia
2. To describe how intraoperative pain is managed4, and to describe how successful practice strategies are
3. To evaluate day-1 and 6-week patient-reported outcomes related to intraoperative pain during Caesarean birth
4. To evaluate the physical and psychological impact on patients of caesarean birth in the short- and medium-term using patient-reported outcome measures
Ethics approval(s)Approved 24/05/2024, Leicester Central Research Ethics Committee (2 Redman Place, Stratford, Health Research Authority, E20 1JQ, UK; +44 (0)207 104 8066, +44 (0)207 104 8227, +44 (0)207 104 8284; leicestercentral.rec@hra.nhs.uk), ref: 24/EM/0084
ConditionReproductive health and childbirth
InterventionSONAR-1 is a study of obstetric patients undergoing caesarean sections (CS) in participating hospitals to understand how common intraoperative pain and inadequate neuraxial anaesthesia (NA)(where the patient is made numb, but is not asleep) is.

Data will be collected on all patients meeting the inclusion criteria in our participating UK hospital, UCLH, during the 4-week study period (where the aim is to recruit at least 100 patients). If the pilot study is felt to be feasible, the researchers plan to roll the study out to more hospitals, to get a feel of the scale of this problem in the whole country.

Abbreviation:
Throughout this summary the abbreviation NA is used. This stands for Neuraxial Anaesthesia. This is a collective term used to mean either:
1. An injection into the bottom of the back, which leaves the recipient awake and pain-free during surgery. This is known as a spinal.
2. An injection in the bottom of the back, which is done to place a catheter through which pain medication can be given. This is known as an epidural. If an anaesthetist gives specific additional medication through the epidural, then the epidural can be used to keep a patient comfortable during a caesarean section (CS).

NA is the ideal mode of anaesthesia used for caesarean sections but it is not always possible for medical reasons. In these cases, a general anaesthetic (GA) is used. This is sometimes referred to as ‘going off to sleep’.

Introduction:
We do not have very good information about how well neuraxial anaesthesia during caesarean section performs, nor how intraoperative pain should be managed, or what the outcomes are for patients who experience pain during awake caesarean sections.

The aim of SONAR-1 is to:
1. Estimate how often NA fails and intraoperative pain is experienced during caesarean section
2. To use patient-centred tools to assess the impact on patients who experience pain during a caesarean section

Who will we involve?
Every adult patient who has a caesarean section, including if the caesarean section is planned or unplanned (an urgent or emergency case), at any time of day or night, and is done awake using NA.

Data collection:
There will be three points of data collection.
Form 1 will be completed by the responsible anaesthetist for the case. It will collect basic anaesthetic, obstetric, and surgical information. There will be nothing on Form 1 that is not already routinely collected by hospitals for all caesarean sections.

Form 2 will be filled in by the researcher together with the patient between 18 and 30 hours after the caesarean. It will consist of questions regarding their experience of the caesarean section, any intraoperative pain or discomfort they may have experienced, their satisfaction with the anaesthetic care, and their quality of the recovery. It is estimated that this will take about 10-15 minutes.

Form 3 will be filled in by a researcher who calls the patient approx. 6 weeks after the caesarean section. The form will consist of questionnaires to help identify the impact to those who have had any negative experiences, compared to those who did not. These are validated questionnaires that are used to identify post-traumatic stress, anxiety, and post-natal depression. This will probably take about 10-15 minutes.

Should a patient score above a specific threshold on these Form 3 questionnaires, they will receive a letter informing them, with a list of resources. Their GP will also be informed by letter.

The results of this study will help us to better understand and manage pain during caesarean section, but also have better information when consenting patients for caesarean section and discussing risks.

Study schedule:
The patient is given a Patient Information Sheet about the surgery as early as possible within reason. This might be in a clinic, or a delivery suite, or a consultant-led labour ward. If there are any study-specific questions, these will be answered by a researcher on site. In urgent or emergency cases, this may occur after the baby is born.

Patients are approached to be consented into the study at the earliest opportunity after the caesarean section within reason. This will likely be in the recovery area.

If the patient has been given the Patient Information Sheet after the baby is born, then they will be given at least one hour to consider the information before being approached for consent.

Form 1 will have already been completed by the anaesthetist, and as it is solely obstetric, anaesthetic and surgical data that is routinely collected, consent is not required.

All patients who consent will be entered into the study log so that they can be followed up at 24 hours and 6 weeks. Patients who do not consent are also entered into the study log kept on site, but only so that researchers know how many people do not wish to consent. They will not then be contacted by the researchers.

Only researchers who have undergone confidentiality and research method training will have access to the study log.

Patients who do consent will complete Form 2 with a researcher no later than 24 hours (+/- 6 hours) after the caesarean section.

Patients will then be contacted by telephone using a number they provide whilst completing Form 2 at 6 weeks (+/- 3 days) following the caesarean section. Three attempts will be made to contact the patients, but appropriate judgement will be used as it is not always possible to find time to speak on the phone in the newborn period. It is anticipated that Form 3 will take 15 minutes to complete. Researchers will be led by the patients as to when might be a good time for us to call.

All the information from all the forms is entered into a study database, and there is no identifiable patient information on that database. It is specifically encrypted so that no one can be identified by looking at the database.

Withdrawal:
Participants are free to withdraw from the study at any time and without reason. This will be recorded in the study log only to prevent unnecessary follow-up.

If they withdraw before recruitment is complete, their data will be removed from the study log and not used for analysis. If withdrawal is after the study closes, it will not be possible to remove their data as analysis will have started. This will be made clear on the study Information Sheet.
Intervention typeProcedure/Surgery
Primary outcome measureThe incidence of patient-reported intraoperative pain during caesarean delivery performed with neuraxial anaesthesia
Secondary outcome measures1. Pain measured using the visual analog scale at 24 hours (+/- 6 hours) after delivery of the baby
2. Maternal satisfaction measured using the Maternal Satisfaction questionnaire tool at 24 hours (+/- 6 hours) after delivery of the baby
3. Pain measured using the visual analog scale at 6 weeks (+/- 3 days) after delivery of the baby
4. Anxiety measured using the Generalised Anxiety Disorder Scale (GAD7) at 6 weeks (+/- 3 days) after delivery of the baby
5. Post-traumatic stress measured using the Post-Traumatic Stress Checklist (PCL-5) at 6 weeks (+/- 3 days) after delivery of the baby
6. Depression measured using the Edinburgh Postnatal Depression Score (EPDS) at 6 weeks (+/- 3 days) after delivery of the baby
Overall study start date10/04/2019
Overall study end date01/08/2025

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participantsPlanned Sample Size: 1500; UK Sample Size: 1500
Participant inclusion criteria1. Aged 18 years or above
2. Gestation beyond 32/40 weeks
3. Receiving NA (spinal, labour epidural extended for surgical anaesthesia or combined spinal epidural)
4. Receiving any scheduled or unscheduled CS of any category
Participant exclusion criteria1. Patient refusal
2. Patients who are unable to provide informed consent
3. Other modes of delivery (e.g., instrumental delivery)
4. De novo GA as an anaesthetic method
Recruitment start date17/03/2025
Recruitment end date17/05/2025

Locations

Countries of recruitment

  • Australia
  • England
  • Northern Ireland
  • Scotland
  • United Kingdom
  • Wales

Study participating centres

Uclh
250 Euston Road
London
NW1 2PQ
United Kingdom
Eligible NHS Hospitals
-
United Kingdom

Sponsor information

University College London
University/education

UCLH/UCL Joint Research Office UCL (part of the Research Support Centre)
1st Floor Maple House (Suite B)
124 Tottenham Court Road
London
W1T 7DN
England
United Kingdom

Phone +44 (0)203 447 5696
Email uclh.randd@nhs.net
Website http://www.ucl.ac.uk/
ROR logo "ROR" https://ror.org/02jx3x895

Funders

Funder type

Government

National Institute of Academic Anaesthesia
Government organisation / Local government
Alternative name(s)
NIAA
Location
United Kingdom
National Institute of Academic Anaesthesia
Government organisation / Local government
Alternative name(s)
NIAA
Location
United Kingdom

Results and Publications

Intention to publish date01/10/2026
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe data-sharing plans for the current study are unknown and will be made available at a later date

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version 1.2 21/05/2024 29/07/2024 No Yes
Protocol file 29/07/2024 No No

Additional files

45562_PIS.pdf
45562_LayProtocol.pdf

Editorial Notes

03/06/2024: Study's existence confirmed by the NIHR.